SUMMARY The frequency and concentration of specific factors binding P2 microglobulin were investigated in sera and synovial fluids of patients and in sera of normal controls. High anti-P2m
concentration is also characteristic of systemic lupus erythematosus (SLE) patients even with normal renal functions,4 the joint effusions of rheumatoid arthritis (RA) patients,5 and the saliva of patients with Sj6gren's disease. 6 Furthermore serum autoantibodies specific for P2m have been observed in SLE patients,7 representing a considerable part of the lymphocytotoxic human antibodies reactive against surface antigens.8
We previously reported our preliminary observations on the appearance of specific autoantibodies for P2m (partly coisolated with rheumatoid factors) in sera and synovial fluids (SF) of RA patients.9
Moreover, IgG complexes containing r2m from some sera and SFs of SLE and RA patients were detected and analysed.10 11 We report here that anti-r2m autoantibodies, reactive with staphylococcal protein A Sepharose (SPrA), can be frequently detected in sera of RA patients and especially in those with extra-articular symptoms.
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Rheumatoid factor titres and immune complexes were also investigated in the sera of RA patients. r2m binding was not significantly related to RF positivity or with immune complexes (Table 1) .
To elucidate the immunochemical nature of the P2m-binding activity precipitable by 50% saturated (Table 2) .
In gel filtration experiments we separated the 3 macromolecular fractions from 3 sera and 3 SFs with high and from 2 sera with low ,32m binding activity. In the 6 positive cases the majority of the binding activity was recovered in the second 'IgG' peak, while only insignificant binding was found in peaks of negative samples. Fig. 3 shows typical elution patterns from sera of RA patients with high ( Fig. 3a) and with low (Fig. 3b) (Fig. 3c) . 
Discussion
The data reported here confirm our previous observations9 on the incidence of anti-r2m autoantibodies in the sera and synovial fluids of RA patients and focus our attention especially on those with different extra-articular manifestations (predominantly pulmonary and nodular). Findings in radioimmune Farr's assay clearly show the prevalence of anti r2m factors in this subgroup of patients. In sera of patients with SLE a similar frequency of positivity was reported. 7 We have also investigated serum samples from 30 patients with SLE (unpublished observation) in the same system and found a comparable high mean of binding percentage (30 5+7-0) and the same incidence of positive sera (16 66%) .
Furthermore the binding of r2m by globulins from SFs of RA patients (22 5 ± 11 5 %) exceeded that of SFs from OA patients (141 ±9 2%). 
